title: Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up.
authors.forename: F T
authors.initials: FT
authors.lastname: Yoshida
authors.forename: C
authors.initials: C
authors.lastname: Takahashi
authors.forename: L A
authors.initials: LA
authors.lastname: Mercadante
authors.forename: I F
authors.initials: IF
authors.lastname: Camargo
authors.forename: H G
authors.initials: HG
authors.lastname: Schatzmayr
mesh_terms: D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000032:analysis / Q000096:biosynthesis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D007117:Immunization, Secondary; D008297:Male; D010564:Personnel, Hospital; D006435:Renal Dialysis; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines / Q000276:immunology*
chemical_list: D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines